Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6RXD
|
||||
| Drug Name |
[2-(1H-Benzoimidazol-4-yloxy)-ethyl]-[3-(1H-indol-3-yl)-propyl]-amine
|
||||
| Synonyms |
CHEMBL331609
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H22N4O
|
||||
| Canonical SMILES |
C(CNCCOc1cccc2[nH]cnc12)Cc3c[nH]c4ccccc34
|
||||
| InChI |
InChI=1S/C20H22N4O/c1-2-7-17-16(6-1)15(13-22-17)5-4-10-21-11-12-25-19-9-3-8-18-20(19)24-14-23-18/h1-3,6-9,13-14,21-22H,4-5,10-12H2,(H,23,24)
|
||||
| InChIKey |
KDBNOLRCLHHEBP-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.